Cargando…

SUN-416 Ipilimumab Associated Hypophysitis and Thyroiditis

INTRODUCTION Ipilimumab, an anti cytotoxic T lymphocyte associated antigen 4 (CTLA 4) antibody, is approved for use in advanced melanoma based upon survival benefit. Anti CTLA 4 antibodies are associated with a myriad of side effects. CLINICAL CASE A 65 year old male with stage 3A malignant melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazi, Fatima, Khan, Muhammad, Adhikari, Sujeen, Chadaga, Amar, Yasmeen, Tahira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552704/
http://dx.doi.org/10.1210/js.2019-SUN-416

Ejemplares similares